Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement

Alvotech priced a $152 million public offering of 22.67 million ordinary shares at $3.75 per share, with an additional concurrent private placement of 17.83 million shares at the same price expected to raise approximately $67 million. The company plans to use net proceeds for biosimilar development, working capital, and potential debt repayment. The offering is expected to close on June 17, 2026, with the private placement closing around June 25, 2026.